XML 35 R29.htm IDEA: XBRL DOCUMENT v3.25.3
Equity Incentive Plans (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of option activities under the 2005 Stock Plan, as amended in January 2010 and November 2012 (the “2005 Plan”) and 2017 Equity Incentive Plan (the “2017 Plan”) during the nine months ended September 30, 2025 is as follows:

 

 

Number
of Options
Outstanding

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Grant Date Fair Value per Option

 

 

Aggregate Intrinsic Value Exercised (in thousands)

 

 

Weighted-
Average
Remaining Contractual term (in years)

 

Outstanding at December 31, 2024

 

 

1,774,388

 

 

$

26.62

 

 

 

 

 

 

 

 

 

 

Granted

 

 

131,470

 

 

$

15.05

 

 

$

9.02

 

 

 

 

 

 

 

Exercised

 

 

(4,104

)

 

$

4.48

 

 

 

 

 

$

46

 

 

 

 

Canceled

 

 

(150,551

)

 

$

23.80

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2025

 

 

1,751,203

 

 

$

26.04

 

 

 

 

 

 

 

 

 

 

Exercisable at September 30, 2025

 

 

1,308,374

 

 

$

27.87

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2025

 

1,751,203

 

 

$

26.04

 

 

 

 

 

$

822

 

 

 

6.29

 

Schedule of Unvested Restricted Stock Units Awards Activity

A summary of restricted stock unit (“RSU”) activities under the 2017 Plan during the nine months ended September 30, 2025 is as follows:

 

 

Number
of RSUs

 

 

Weighted-
Average
Grant Date Fair Value per RSU

 

 

Aggregate Fair Value of RSUs Vested (in thousands)

 

Unvested RSUs at December 31, 2024

 

 

966,131

 

 

$

19.04

 

 

 

 

Granted

 

 

1,852,388

 

 

$

16.10

 

 

 

 

Vested

 

 

(244,990

)

 

$

19.84

 

 

$

3,680

 

Forfeited

 

 

(215,454

)

 

$

17.15

 

 

 

 

Unvested RSUs at September 30, 2025

 

 

2,358,075

 

 

$

16.82

 

 

 

 

Schedule of Stock-Based Compensation Expense for All Award Types Recorded in Consolidated Statements of Operations

Total stock-based compensation expense associated with the 2005 Plan, 2017 Plan and 2017 ESPP is recorded in the condensed consolidated statements of operations and was allocated as follows (in thousands):

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenues

$

387

 

 

$

360

 

 

$

1,655

 

 

$

1,199

 

Sales and marketing

 

393

 

 

 

560

 

 

 

1,558

 

 

 

1,745

 

Research and development

 

304

 

 

 

284

 

 

 

1,141

 

 

 

889

 

General and administrative

 

1,968

 

 

 

1,850

 

 

 

5,943

 

 

 

5,294

 

Total

$

3,052

 

 

$

3,054

 

 

$

10,297

 

 

$

9,127